Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical company developing innovative treatments for patients with unmet medical needs, announced new ...

Odds for developing Parkinson’s disease increased with newer groundwater and with carbonate aquifers, according to a poster ...

New registry connects patients and researchers to accelerate understanding and improve care in autoimmune neurological diseases ...

Tom Davies was diagnosed with motor neuron disease (MND) at 29, which has left him unable to walk or eat. Doctors believe his ...

The link between multiple sclerosis and kissing disease emphasizes the complicated interaction between infections and chronic ...

Neurological disorders represent a highly complex area within medicine, characterized by multifactorial etiologies involving disruptions across numerous ...

Scientists argue that Parkinson's disease complexity demands a new way of classifying the disease for research purposes, one based not on clinical diagnosis but biology. The authors have called their ...

Brenig Therapeutics Inc. (Brenig), a clinical-stage biotechnology company developing brain-penetrant small molecule therapies for neurodegenerative diseases, today announced that data from its ongoing ...

BioVie Inc. (NASDAQ: BIVI) ('BioVie” or the 'Company”), a clinical-stage company developing innovative drug therapies for neurological and neurodegenerative diseases, today announced the acceptance of ...

Motor function improved with a favorable safety profile for patients with Parkinson’s disease who used tavapadon while receiving oral levodopa, according to a study published in JAMA Neurology.This ...

A Surrey couple say they have been left disappointed and frustrated with the province, as they seek help to pay for therapy ...